Related Experiment Video
Updated: Aug 29, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Leprosy (Hansen's Disease)
1Department of Neurological Sciences, Cook County Hospital and Rush Medical College, 1835 West Harrison Street, Chicago, IL 60612, USA. rbartt@rush.edu
Abstract:
Leprosy (Hansen's disease) causes the most common treatable form of neuropathy in the world. Several endemic countries account for the majority of the world's cases and most of the cases seen in the US are amongst immigrants. However, endemic cases of leprosy occur in the US. The pathogen is Mycobacterium leprae, a slow-growing, obligate intracellular pathogen that consistently infects skin and peripheral nerves. The clinical appearance of the skin and neurologic deficits develop months to years after infection and are determined by the host's response to the infection. An individual's disease classification can change over time based on the immune status of the individual. Immune-mediated "reactional states" may also occur that require additional recognition and treatment. Varied in its manifestations, a successful treatment approach relies on proper recognition and classification of disease.
Insights
Leprosy, also known as Hansen's disease, is a treatable neuropathy caused by Mycobacterium leprae. Early recognition and classification are crucial for effective treatment, as manifestations and immune responses vary.
Area of Science:
- Infectious Diseases
- Neurology
- Immunology
Background:
- Leprosy (Hansen's disease) is the most common treatable neuropathy globally.
- While many cases occur in endemic countries and among US immigrants, endemic leprosy exists within the US.
- Mycobacterium leprae, the causative agent, is a slow-growing pathogen infecting skin and peripheral nerves.
Purpose of the Study:
- To highlight the importance of recognizing and classifying leprosy.
- To emphasize the variability in clinical presentation and disease progression.
- To underscore the need for tailored treatment strategies based on host immune response and reactional states.
Main Methods:
- This abstract does not detail specific methods but discusses the clinical aspects of leprosy.
- Focuses on the pathogen, its targets, and disease development over time.
- Considers the role of host immune response in disease manifestation and classification.
Main Results:
- Clinical presentation and neurological deficits appear months to years post-infection.
- Disease classification is dynamic, influenced by the host's immune status.
- Immune-mediated reactional states necessitate specific recognition and management.
Conclusions:
- Successful leprosy treatment hinges on accurate recognition and classification of the disease.
- Understanding the host's immune response is critical for managing varied manifestations.
- Prompt identification and management of reactional states are essential for effective patient care.
Related Concept Videos
Leishmaniasis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Sexually Transmitted Infections
